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STUDY PROTOCOL Open Access
Preventing food allergy: protocol for a rapid
systematic review
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Abstract
Background: The European Academy of Allergy and Clinical Immunology is developing guidelines about how to
prevent and manage food allergy. As part of the guidelines development process, a systematic review is planned to
examine published research about the prevention of food allergy. This systematic review is one of seven inter-linked
evidence syntheses that are being undertaken in order to provide a state-of-the-art synopsis of the current evidence
base in relation to epidemiology, prevention, diagnosis and clinical management, and impact on quality of life, which
will be used to inform clinical recommendations. The aim of this systematic review will be to assess the effectiveness of
approaches for the primary prevention of food allergy.
Methods: Seven bibliographic databases will be searched from their inception to September 30, 2012 for systematic
reviews, randomized controlled trials, quasi-randomized controlled trials, controlled clinical trials, controlled before-and
-after studies, interrupted time series and cohort studies. Cohort studies will be included due to an inability to
randomize with interventions such as breastfeeding. Studies that focused on the development of either food
sensitization (a proxy measure) or food allergy will also be eligible for inclusion. Studies will be critically appraised using
the Critical Appraisal Skills Program and Cochrane Risk of Bias tools, as appropriate.
Discussion: There is a lack of rigorous evidence to support recommendations about how to prevent the development
of food allergy. It would appear that it is important to see the prevention of food allergy in the context of individual,
family and wider factors that may influence its development. There is much left to learn about preventing food allergy,
and this is a priority given the high societal and healthcare costs involved. This systematic review will help to further
this learning.
Keywords: Food allergy, lLgE-mediated, Prevention
Background
Allergies to foods such as milk, eggs, peanuts and tree
nuts can have a significant effect on people’s quality of
life and physical functioning, and can also be costly in
terms of medical visits and treatments [1]. Given the
morbidity resulting from food allergy, there is consider-
able scientific, professional and lay interest in ap-
proaches that may reduce the risk of individuals
developing food allergy. A wide range of antenatal, peri-
natal, neonatal and childhood interventions have been
investigated, and it is therefore important that data
about the effectiveness and safety of these primary pre-
vention strategies is assessed and synthesised.
The European Academy of Allergy and Clinical Im-
munology (EAACI) is developing guidelines about how
to prevent and manage food allergy. As part of the
guidelines development process, a systematic review is
planned to examine published research about the pre-
vention of food allergy. This systematic review is one of
seven inter-linked evidence syntheses that are being
undertaken in order to provide a state-of-the-art synop-
sis of the current evidence base in relation to epidemi-
ology, prevention, diagnosis and clinical management,
and impact on quality of life, which will be used to in-
form clinical recommendations.
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Aims
The aim of this systematic review will be to assess the
effectiveness of approaches for the primary prevention
of food allergy.
Scope
The umbrella term ‘food hypersensitivity’ is used to de-
scribe any adverse reaction to food [2]. The term ‘food
allergy’ refers to the subgroup of food-triggered reac-
tions in which immunological mechanisms have been
implicated, whether IgE-mediated, non-IgE-mediated, or
involving a combination of IgE- and non-IgE-mediated
etiologies [3]. All other reactions to food that have
sometimes been referred to as ‘food intolerance’ consti-
tute non-allergic food hypersensitivity reactions and are
outside the focus of this enquiry.
The topic of food allergy is complicated by the fact
that IgE-mediated reactions can manifest as angioedema,
urticaria, atopic eczema/dermatitis, oral allergy syn-
drome and anaphylaxis, for example. Non-IgE-mediated
immunological reactions result from activation of other
immunological pathways (e.g. T-cell mediated) and can
manifest as atopic eczema/dermatitis, gastro-esophageal re-
flux disease, food protein-induced enterocolitis, proctocolitis,
and enteropathy syndromes. The contemporary definition of
food allergy thus includes several clinical entities with dif-
ferent pathophysiologies resulting from exposure to differ-
ent foods [4]. For simplicity, the review will only examine
studies that seek to prevent food allergy or food sensitivity
as a primary or secondary outcome. Studies seeking to
prevent other manifestations such as eczema will not be
included. Coeliac disease is an important non-IgE medi-
ated condition but as it has distinct symptoms and prog-
nosis different from atopic conditions it will be excluded
from this review [4et].
Methods
Inclusion criteria
We have conceptualised the review to incorporate the
interventions, study designs and outcomes, as shown in
Figure 1: Conceptualisation of systematic review on the
prevention of food allergy.
Study designs eligible for inclusion in the review
comprise:
 systematic reviews with or without meta-analyses
 randomised controlled trials
 quazi-randomised controlled trials and controlled
clinical trials (defined as studies where the
comparison group is not fully randomised)
 controlled before and after studies (only where a clearly
defined comparison group is available prospectively)
and interrupted time series studies (where measures are
taken during at least three time points before and at
least three time points after intervention)
 prospective cohort studies.
We suspect that there will be limited information
available from systematic reviews and randomised trials,
so we have opted to include lower forms of evidence
where non-random allocation of patients has occurred
[5]. Prospective cohort studies, despite being lower
forms of evidence, will be included as advice from ex-
perts at EAACI suggests that studies looking at
breastfeeding and its role in preventing food allergy will
be missed by the other study designs.
Studies already included in other systematic reviews
will be eligible for quality appraisal and inclusion in this
review. Where repeated reports of the same study are
identified, the most up-to-date or detailed will be in-
cluded unless there is a good clinical reason to include
earlier studies.
Figure 1 Conceptualisation of systematic review on the prevention of food allergy.
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Only research published as full papers will be eligible
for inclusion.
Exclusion criteria
The following material will be excluded from the review:
 non-systematic reviews, discussion papers, non-
research letters and editorials
 qualitative studies
 case studies, case series, non-controlled before and
after studies, and other lower quality designs
 animal studies
 abstracts and studies not available in full form
 unpublished material
 studies about risk factors (as these are covered in
another review in the series).
Search strategy
We will search the following databases:
 Cochrane Library, including:
o Cochrane Database of Systematic Reviews
(CDSR)
o Database of Reviews of Effectiveness (DARE)
o CENTRAL (Trials)
o Methods Studies
o Health Technology Assessments (HTA)
o Economic Evaluations Database (EED)
 MEDLINE (OVID)
 Embase(OVID)
 CINAHL (Ebscohost)
 ISI Web of Science (Thomson Web of Knowledge)
 TRIP Database (www.tripdatabase.com)
 Clinicaltrials.gov (NIH web)
A highly sensitive search strategy has been developed
and validated study design filters will be applied to re-
trieve relevant articles. To retrieve systematic reviews,
we will use the systematic review filter developed at
McMaster University Health Information Research Unit
(HIRU). To retrieve randomised controlled trials (RCTs),
we will apply the Cochrane strategy for identifying trials
in MEDLINE: sensitivity- and precision-maximising ver-
sion (2008 revision); Ovid format from Chapter 6 of the
Cochrane Handbook [6]. To retrieve non-randomised
studies, i.e. controlled clinical trials (CCT), controlled
before-and-after (CBA), and interrupted time-series
(ITS) studies, we will use the Cochrane Effective Practice
and Organisation of Care (EPOC) filter Version 2.4,
available on request from the EPOC Group [7,8]. Cohort
studies will be retrieved using methods that have been
developed in the context of other systematic reviews.
The search strategy has been devised on OVID MEDLINE
and then adapted for the other databases (see Additional file
1 for full search strategies). In all cases the databases will be
searched from inception to 30 September 2012. Additional
references will be located through searching the references
cited in systematic reviews and through discussion with ex-
perts in the field. We will invite experts who are active in
the field from a range of disciplines and locations to com-
ment on our search strategy and the list of included studies.
No language restrictions will be applied and, where possible,
all literature will be translated. Additional studies will be
sourced through experts in the field and hand-searching up
until 31 December 2012. All references will be imported
into an EndNote Library and tagged with the name of the
database.
Study selection
The titles of identified studies will be checked independ-
ently by two reviewers according to the above selection
criteria, and categorised as: included, not included and
unsure. For those papers in the unsure category, we will
retrieve the abstract and re-categorise as above. Any dis-
crepancies will be resolved by consensus and, if neces-
sary, a third reviewer will be consulted. Full text copies
of potentially relevant studies will be obtained and their
eligibility for inclusion independently assessed. Studies
that do not fulfil all of the inclusion criteria will be
excluded.
Quality assessment strategy
Quality assessments will independently be carried out
on each study by two reviewers using the relevant ver-
sion of the Critical Appraisal Skills Programme (CASP)
quality assessment tool for systematic reviews [9]. We
will assess the risk of bias using the criteria suggested by
EPOC [10]. RCTs, CCTs and CBAs will be assessed for
generation of allocation sequence, concealment of alloca-
tion, baseline outcome measurements, baseline character-
istics, incomplete outcome data, blinding of outcome
assessor, protection against contamination, selective out-
come reporting and other risks of bias. For ITS designs
we will also assess the independence of the intervention
from other changes, the pre-specified shape of the inter-
vention and if the intervention was unlikely to affect data
collection. These assessments will draw on the principles
incorporated into the Cochrane EPOC guidelines for
assessing intervention studies [11] and the Strengthening
the Reporting of Observational Studies in Epidemiology
for assessing observational studies [12]. Any discrepancies
will be resolved by discussion or, if agreement cannot be
reached, by arbitration by a third reviewer.
Analysis, data synthesis and reporting
Data will be independently extracted onto a customised
data extraction sheet by two reviewers, and any discrep-
ancies will be resolved by discussion or, if agreement
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cannot be reached, by arbitration by a third reviewer. A
descriptive summary with data tables will be produced
to summarise the literature. The focus will be a narrative
synthesis. If clinically and statistically appropriate, meta-
analysis using either fixed-effect or random-effects mod-
elling will be undertaken using methods suggested by
Agresti and Coul [13].
This review has been registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
and has registration number CRD42013003709 allocated
to it. The Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) checklist will be used
to guide the reporting of the systematic review [14].
Discussion
To date, there exists a lack of rigorous evidence to sup-
port recommendations about how to prevent the devel-
opment of food allergy. There is some evidence to
support breastfeeding and partially or extensively hydro-
lyzed whey and casein formula to prevent food allergy,
especially in infants at high-risk. However, there is little
evidence to support recommending changes to the diets
of pregnant or lactating mothers, supplements for
mothers or infants or delaying the introduction of solid
foods as a way of protecting against food allergy. Multi-
faceted interventions that reduce exposure to both food
and environmental allergens may be worth further
exploration.
It would appear that it is important to see the preven-
tion of food allergy in the context of individual, family
and wider factors that may influence its development.
Large trials are ongoing to examine some components,
such as the timing of introducing potentially allergenic
foods. Education interventions and strategies that target
the determinants of food allergy, especially in those at
high-risk, may also be worth investigating further using
high quality designs. There is much left to learn about
preventing food allergy, and this is a priority given the
high societal and healthcare costs involved. We believe
that this systematic review will help to further the learn-
ing and identify gaps that need to be filled through fu-
ture research endeavours.
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